This week, most of the largest U.S. startup funding rounds centered around the sector one would suspect: artificial intelligence. Beyond that, the next-biggestThis week, most of the largest U.S. startup funding rounds centered around the sector one would suspect: artificial intelligence. Beyond that, the next-biggest

The Week’s 10 Biggest Funding Rounds: AI Drives Another Spree Of Megadeals

이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

Want to keep track of the largest startup funding deals in 2026 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board.

This is a weekly feature that runs down the week’s top 10 announced funding rounds in the U.S. Check out last week’s biggest funding deal roundup here.

This week, most of the largest U.S. startup funding rounds centered around the sector one would suspect: artificial intelligence. This was true for the week’s largest venture financing, a $1.5 billion Series F for AI inference technology provider Baseten, as well as a majority of rounds in the Top 10. Beyond that, the next-biggest area for startup funding was biotech.

1. Baseten, $1.5B, AI inference technology: Baseten, a provider of systems software to run AI applications workloads, raised $1.5 billion in Series F funding, its fourth fundraise in 18 months. Altimeter Capital, Conviction Partners, Spark Capital, Sands Capital and Wellington Management co-led the round, which set a $13 billion valuation for the San Francisco-based company.

2. AppsFlyer, $1B, digital marketing: AppsFlyer, a San Francisco-based provider of data analytics with digital marketing as a core use case, reportedly secured more than $1 billion in a Series E funding round at a post-money valuation of $2.7 billion. Backers reportedly include Unity, Meta, Moloco and Google.

3. Groq, $650M, AI inference technology: San Francisco-based Groq closed on $650 million in new funding led by Infinitum and Disruptive that it says will be used to scale its AI inference cloud technology and infrastructure. The investment comes just over six months after an acquihire-type transaction in which Nvidia hired away its founder and key team members and licensed its technology.

4. Ollin Biosciences, $330M, ophthalmic therapies: Ollin Biosciences, a developer of therapies for vision-threatening diseases, picked up $330 million in Series B funding. TCG Crossover and Arch Venture Partners led the financing for the Austin-based company.

5. General Intuition, $320M, foundational AI: General Intuition, developer of a foundational AI model based on gameplay, secured $320 million in Series A funding at a $2.3 billion valuation. Khosla Ventures led the financing for the New York-based company, while backers including Jeff Bezos and General Catalyst participated.

6. Peregrine Technologies, $250M, government software: Peregrine Technologies, provider of a platform used by public safety agencies and other government entities, secured $250 million in Series D financing. Fifth Down Capital, Sequoia Capital, O.G. Venture Partners, Goldcrest Capital, XYZ Ventures and Godfrey Capital led the financing, which set a $6.8 billion valuation for the San Francisco-based company.

7. (tied) Quantifind, $200M, risk intelligence: Palo Alto, California-based Quantifind, developer of a risk intelligence platform for financial crime detection and national security operations, closed on $200 million in growth financing led by Summit Partners.

7. (tied) Mirendil, $200M, foundational AI: San Francisco-based Mirendil, a frontier lab building systems that excel at AI R&D, says it raised a seed round of $200 million led by Andreessen Horowitz and Kleiner Perkins. The startup also counts Nvidia as a backer.

9. (tied) Upscale AI, $190M, AI infrastructure: AI networking infrastructure startup Upscale AI raised $190 million in Series A extension funding, bringing total financing to $500 million. Premji Invest led the round, which set a $2 billion valuation for the Santa Clara, California-based company.

9. (tied) Osanni Bio, $190M, biotech: San Francisco-based Osanni Bio, a therapeutics platform focused on ophthalmic therapies and other treatments, secured $190 million in Series B funding led by Patient Square Capital.

Large non-US deals:

The week also brought some large European rounds:

Stark, $569M, defense tech: Berlin-based defense tech startup Stark reportedly raised $569 million in a financing led by Founders Fund and Sequoia Capital.

Alan, $546M, insurance: Paris-based health insurance startup Alan secured $460 million in new investment in primary and secondary equity led by Prosus.

Methodology

We tracked the largest announced rounds in the Crunchbase database that were raised by U.S.-based companies for the period of June 18-26. Although most announced rounds are represented in the database, there could be a small time lag as some rounds are reported late in the week.

Illustration: Dom Guzman

시장 기회
Gensyn 로고
Gensyn 가격(AI)
$0.03609
$0.03609$0.03609
+16.19%
USD
Gensyn (AI) 실시간 가격 차트

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.